(19)
(11) EP 3 667 261 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.09.2021 Bulletin 2021/37

(45) Mention of the grant of the patent:
11.08.2021 Bulletin 2021/32

(21) Application number: 19211307.4

(22) Date of filing: 05.05.2016
(51) International Patent Classification (IPC): 
G01F 23/02(2006.01)
A61B 10/00(2006.01)
A61B 5/154(2006.01)
 A61J 1/05(2006.01)
A61B 5/15(2006.01)
(52) Cooperative Patent Classification (CPC):
A61B 5/15003; A61B 5/150755; A61B 5/150786; A61B 5/150992; A61B 5/154; A61B 10/0045

(54)

METHOD FOR VERIFYING A SAMPLE VOLUME

VERFAHREN ZUR ÜBERPRÜFUNG EINES PROBENVOLUMENS

PROCÉDÉ POUR VÉRIFIER UN VOLUME D'ÉCHANTILLON

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 05.05.2015 US 201562157145 P

(43) Date of publication of application:
17.06.2020 Bulletin 2020/25

(60) Divisional application:
21184923.7

(62) Application number of the earlier application in accordance with Art. 76 EPC:
16790058.8 / 3292382

(73) Proprietor: Magnolia Medical Technologies, Inc.
Seattle, WA 98119 (US)

(72) Inventors:
  • Bullington, Gregory J.
    Bellevue, Washington 98006 (US)
  • Gaw, Shan E.
    Seattle, Washington 98103 (US)
  • Miazga, Jay M.
    Seattle, Washington 98103 (US)
  • Eubanks, Shannon E.
    Seattle, Washington 98121 (US)

(74) Representative: Gill Jennings & Every LLP 
The Broadgate Tower 20 Primrose Street
London EC2A 2ES
London EC2A 2ES (GB)


(56) References cited: : 
WO-A1-2008/031036
US-A1- 2015 094 615
 US-A1- 2011 042 255
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).